Suppr超能文献

2,3,7,8-四氯二苯并-对-二恶英对[³H]胸腺嘧啶核苷掺入大鼠肝脏脱氧核糖核酸的影响。

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on [3H]thymidine incorporation into rat liver deoxyribonucleic acid.

作者信息

Christian B J, Peterson R E

出版信息

Toxicology. 1983 Sep;28(1-2):133-46. doi: 10.1016/0300-483x(83)90112-9.

Abstract

The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on [3H]thymidine incorporation into hepatic DNA was studied in rats. In non-hepatectomized male and female animals, incorporation measured at the peak of the first round of liver DNA synthesis after TCDD treatment (10 micrograms/kg) was similar to that of control animals. In contrast, the first round of [3H]thymidine incorporation after a 1/3 hepatectomy was enhanced 3-fold in TCDD-treated rats. The enhanced response to 1/3 hepatectomy was produced by doses of TCDD ranging from 1 to 30 micrograms/kg with an apparent ED50 of 5 micrograms/kg. Enhanced incorporation was observed when the 1/3 hepatectomy was performed 5-10 days after an ED50 dose and it returned to the control level after 20 days. This enhanced response was not preceded by changes in food consumption or hepatic activities of ornithine decarboxylase (ODC), tyrosine aminotransferase (TAT) or gamma glutamyl transpeptidase (GGT) when compared to respective control values. Also, the enhanced incorporation was not necessarily due to removal of 1/3 of the liver because it was also seen in TCDD-treated rats that were laparotomized. The mechanism of enhancement in laparotomized animals does not appear to involve a diminished response of the liver to the inhibitory effects of adrenal hormones on liver DNA synthesis. This was suggested by the finding that an adrenalectomy prior to the laparotomy did not block the enhanced incorporation of [3H]thymidine into hepatic DNA. The mechanism by which TCDD enhances the first round of liver DNA synthesis after a 1/3 hepatectomy or laparotomy remains to be determined.

摘要

在大鼠中研究了2,3,7,8 - 四氯二苯并 - p - 二恶英(TCDD)对[³H]胸苷掺入肝脏DNA的影响。在未进行肝切除的雄性和雌性动物中,TCDD处理(10微克/千克)后第一轮肝脏DNA合成高峰期测得的掺入量与对照动物相似。相比之下,在接受1/3肝切除的大鼠中,TCDD处理后第一轮[³H]胸苷掺入量增强了3倍。对1/3肝切除的增强反应是由1至30微克/千克剂量的TCDD产生的,其表观半数有效剂量(ED50)为5微克/千克。当在ED50剂量后5至10天进行1/3肝切除时观察到掺入增强,并且在20天后恢复到对照水平。与各自的对照值相比,这种增强反应之前并未出现食物摄入量或肝脏鸟氨酸脱羧酶(ODC)、酪氨酸转氨酶(TAT)或γ-谷氨酰转肽酶(GGT)活性的变化。此外,增强的掺入不一定是由于切除了1/3的肝脏,因为在接受剖腹手术的TCDD处理大鼠中也观察到了这种情况。剖腹手术动物中增强的机制似乎不涉及肝脏对肾上腺激素抑制肝脏DNA合成作用的反应减弱。这一点由以下发现表明:在剖腹手术前进行肾上腺切除术并未阻止[³H]胸苷增强掺入肝脏DNA。TCDD增强1/3肝切除或剖腹手术后第一轮肝脏DNA合成的机制仍有待确定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验